Acumen Pharmaceuticals, Inc. (ABOS): Price and Financial Metrics
ABOS Price/Volume Stats
| Current price | $2.37 | 52-week high | $5.09 |
| Prev. close | $2.39 | 52-week low | $2.08 |
| Day low | $2.32 | Volume | 180,500 |
| Day high | $2.45 | Avg. volume | 324,701 |
| 50-day MA | $2.61 | Dividend yield | N/A |
| 200-day MA | $3.06 | Market Cap | 142.39M |
ABOS Stock Price Chart Interactive Chart >
Acumen Pharmaceuticals, Inc. (ABOS) Company Bio
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
ABOS Price Returns
| 1-mo | -15.36% |
| 3-mo | -18.56% |
| 6-mo | -30.29% |
| 1-year | 0.42% |
| 3-year | -75.57% |
| 5-year | N/A |
| YTD | -38.28% |
| 2023 | -28.89% |
| 2022 | -20.12% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...